These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9846917)

  • 1. Intensified treatment of acute childhood lymphoblastic leukaemia has improved prognosis, especially in non-high-risk patients: the Nordic experience of 2648 patients diagnosed between 1981 and 1996. Nordic Society of Paediatric Haematology and Oncology (NOPHO).
    Gustafsson G; Kreuger A; Clausen N; Garwicz S; Kristinsson J; Lie SO; Moe PJ; Perkkiö M; Yssing M; Saarinen-Pihkala UM
    Acta Paediatr; 1998 Nov; 87(11):1151-61. PubMed ID: 9846917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving outcome through two decades in childhood ALL in the Nordic countries: the impact of high-dose methotrexate in the reduction of CNS irradiation. Nordic Society of Pediatric Haematology and Oncology (NOPHO).
    Gustafsson G; Schmiegelow K; Forestier E; Clausen N; Glomstein A; Jonmundsson G; Mellander L; Mäkipernaa A; Nygaard R; Saarinen-Pihkala UM
    Leukemia; 2000 Dec; 14(12):2267-75. PubMed ID: 11187918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA-thioguanine nucleotide concentration and relapse-free survival during maintenance therapy of childhood acute lymphoblastic leukaemia (NOPHO ALL2008): a prospective substudy of a phase 3 trial.
    Nielsen SN; Grell K; Nersting J; Abrahamsson J; Lund B; Kanerva J; Jónsson ÓG; Vaitkeviciene G; Pruunsild K; Hjalgrim LL; Schmiegelow K
    Lancet Oncol; 2017 Apr; 18(4):515-524. PubMed ID: 28258828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A population-based study of 272 children with acute myeloid leukaemia treated on two consecutive protocols with different intensity: best outcome in girls, infants, and children with Down's syndrome. Nordic Society of Paediatric Haematology and Oncology (NOPHO).
    Lie SO; Jonmundsson G; Mellander L; Siimes MA; Yssing M; Gustafsson G
    Br J Haematol; 1996 Jul; 94(1):82-8. PubMed ID: 8757513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic impact of karyotypic findings in childhood acute lymphoblastic leukaemia: a Nordic series comparing two treatment periods. For the Nordic Society of Paediatric Haematology and Oncology (NOPHO) Leukaemia Cytogenetic Study Group.
    Forestier E; Johansson B; Gustafsson G; Borgström G; Kerndrup G; Johannsson J; Heim S
    Br J Haematol; 2000 Jul; 110(1):147-53. PubMed ID: 10930992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paediatric B-cell precursor acute lymphoblastic leukaemia with t(1;19)(q23;p13): clinical and cytogenetic characteristics of 47 cases from the Nordic countries treated according to NOPHO protocols.
    Andersen MK; Autio K; Barbany G; Borgström G; Cavelier L; Golovleva I; Heim S; Heinonen K; Hovland R; Johannsson JH; Johansson B; Kjeldsen E; Nordgren A; Palmqvist L; Forestier E
    Br J Haematol; 2011 Oct; 155(2):235-43. PubMed ID: 21902680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome after first relapse in children with acute lymphoblastic leukemia: a population-based study of 315 patients from the Nordic Society of Pediatric Hematology and Oncology (NOPHO).
    Schroeder H; Garwicz S; Kristinsson J; Siimes MA; Wesenberg F; Gustafsson G
    Med Pediatr Oncol; 1995 Nov; 25(5):372-8. PubMed ID: 7674994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extended intrathecal methotrexate may replace cranial irradiation for prevention of CNS relapse in children with intermediate-risk acute lymphoblastic leukemia treated with Berlin-Frankfurt-Münster-based intensive chemotherapy. The Associazione Italiana di Ematologia ed Oncologia Pediatrica.
    Conter V; Aricò M; Valsecchi MG; Rizzari C; Testi AM; Messina C; Mori PG; Miniero R; Colella R; Basso G
    J Clin Oncol; 1995 Oct; 13(10):2497-502. PubMed ID: 7595699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term results of NOPHO ALL-92 and ALL-2000 studies of childhood acute lymphoblastic leukemia.
    Schmiegelow K; Forestier E; Hellebostad M; Heyman M; Kristinsson J; Söderhäll S; Taskinen M;
    Leukemia; 2010 Feb; 24(2):345-54. PubMed ID: 20010622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Acute lymphoblastic leukaemia in Danish children and young people 10 to 19 years of age. Should young adults with acute lymphoblastic leukaemia be treated in the same way as children?].
    Schrøder H; Kjeldstad M; Boesen AM; Nielsen OJ; Schmidt KG; Johnsen HE; Gregersen H; Gustafsson G
    Ugeskr Laeger; 2006 Jun; 168(26-32):2554-8. PubMed ID: 16824410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebral sinus venous thromboses in children with acute lymphoblastic leukaemia - a multicentre study from the Nordic Society of Paediatric Haematology and Oncology.
    Ranta S; Tuckuviene R; Mäkipernaa A; Albertsen BK; Frisk T; Tedgård U; Jónsson ÓG; Pruunsild K; Gretenkort Andersson N; Winther Gunnes M; Saulyte Trakymiene S; Frandsen T; Heyman M; Ruud E; Helgestad J
    Br J Haematol; 2015 Feb; 168(4):547-52. PubMed ID: 25288392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age- and sex-specific incidence of childhood leukemia by immunophenotype in the Nordic countries.
    Hjalgrim LL; Rostgaard K; Schmiegelow K; Söderhäll S; Kolmannskog S; Vettenranta K; Kristinsson J; Clausen N; Melbye M; Hjalgrim H; Gustafsson G
    J Natl Cancer Inst; 2003 Oct; 95(20):1539-44. PubMed ID: 14559876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolated CNS relapse of acute lymphoblastic leukemia treated with intensive systemic chemotherapy and delayed CNS radiation: a pediatric oncology group study.
    Barredo JC; Devidas M; Lauer SJ; Billett A; Marymont M; Pullen J; Camitta B; Winick N; Carroll W; Ritchey AK
    J Clin Oncol; 2006 Jul; 24(19):3142-9. PubMed ID: 16809737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of central nervous system involvement and irradiation in childhood acute lymphoblastic leukemia: Lessons from the NOPHO ALL-92 and ALL-2000 protocols.
    Taskinen M; Oskarsson T; Levinsen M; Bottai M; Hellebostad M; Jonsson OG; Lähteenmäki P; Schmiegelow K; Heyman M
    Pediatr Blood Cancer; 2017 Feb; 64(2):242-249. PubMed ID: 27748030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensive chemotherapy without radiotherapy gives more than 85% event-free survival for non-Hodgkin lymphoma without central nervous involvement: a 6-year population-based study from the nordic society of pediatric hematology and oncology.
    Márky I; Björk O; Forestier E; Jónsson OG; Perkkiö M; Schmiegelow K; Storm-Mathiesen I; Gustafsson G;
    J Pediatr Hematol Oncol; 2004 Sep; 26(9):555-60. PubMed ID: 15342981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral methotrexate/6-mercaptopurine may be superior to a multidrug LSA2L2 Maintenance therapy for higher risk childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study.
    Schmiegelow K; Heyman M; Kristinsson J; Mogensen UB; Rosthøj S; Vettenranta K; Wesenberg F; Saarinen-Pihkala U;
    J Pediatr Hematol Oncol; 2009 Jun; 31(6):385-92. PubMed ID: 19648786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interphase fluorescent in situ hybridization deletion analysis of the 9p21 region and prognosis in childhood acute lymphoblastic leukaemia (ALL): results from a prospective analysis of 519 Nordic patients treated according to the NOPHO-ALL 2000 protocol.
    Kuchinskaya E; Heyman M; Nordgren A; Söderhäll S; Forestier E; Wehner P; Vettenranta K; Jonsson O; Wesenberg F; Sahlén S; Nordenskjöld M; Blennow E
    Br J Haematol; 2011 Mar; 152(5):615-22. PubMed ID: 21241277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response of children with high-risk acute lymphoblastic leukemia treated with and without cranial irradiation: a report from the Children's Cancer Group.
    Nachman J; Sather HN; Cherlow JM; Sensel MG; Gaynon PS; Lukens JN; Wolff L; Trigg ME
    J Clin Oncol; 1998 Mar; 16(3):920-30. PubMed ID: 9508174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High cure rate with a moderately intensive treatment regimen in non-high-risk childhood acute lymphoblastic leukemia. Results of protocol ALL VI from the Dutch Childhood Leukemia Study Group.
    Veerman AJ; Hählen K; Kamps WA; Van Leeuwen EF; De Vaan GA; Solbu G; Suciu S; Van Wering ER; Van der Does-Van der Berg A
    J Clin Oncol; 1996 Mar; 14(3):911-8. PubMed ID: 8622039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress in the treatment of childhood leukaemias.
    Lie SO; Gustafsson G
    Ann Med; 1992 Oct; 24(5):319-23. PubMed ID: 1418912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.